Epibiotech Co., Ltd. (XKON:446440)
South Korea · Delayed Price · Currency is KRW 14,750
0.00 (0.00%)
At close: Feb 19, 2026
Epibiotech Market Cap
Epibiotech has a market cap or net worth of 33.4 billion as of February 20, 2026. Its market cap has increased by 8.02% in one year.
Market Cap
33.40B
Enterprise Value
n/a
Revenue
449.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
14,750.00
Market Cap Chart
Since July 31, 2023, Epibiotech's market cap has decreased from 58.59B to 33.40B, a decrease of -42.98%. That is a compound annual growth rate of -19.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 33.40B | -3.47% |
| Dec 30, 2025 | 34.60B | -2.83% |
| Dec 30, 2024 | 35.61B | 24.00% |
| Dec 28, 2023 | 28.72B | -50.98% |
| Jul 31, 2023 | 58.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EyeGene | 62.12B |
| NGeneBio | 57.46B |
| J2KBIO | 49.53B |
| Aptamer Sciences | 44.28B |
| MOA Life Plus | 44.07B |
| SCM Lifescience | 37.31B |
| Kainos Medicine | 35.56B |
| Eutilex.Co.,Ltd | 35.32B |